PTEN and fatty liver disease: MiR-21 targets include factors involved in suppressing the development of liver steatosis, particularly phosphatase and tensin homolog (PTEN), which inhibits DNL and FAs uptake [150] or PPARα, triggering lipid oxidation [148].